Aller-Max
On sale on the US market (according to the DSLD)
Country Life, food supplement from the US market
Aller-Max (Country Life), a food supplement au code-barres 015794016090, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. Doses of vitamine A are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 250 mg a day according to the label (at most 1 serving a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Country Life
- Barcode
- 015794016090
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Cellulose, Magnesium Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin A | Vitamin | 750 µg |
| Vitamin C | Vitamin | 250 mg |
| Pantothenic Acid | Vitamin | 200 mg |
| Calcium | Mineral | 50 mg |
| Zinc | Mineral | 10 mg |
| Quercetin | Other substance | 250 mg |
| Aller-Max Blend | Blend | 225 mg |
| Bromelain | Enzyme | not stated |
| Stinging Nettle root extract (Urtica dioica) | Plant | not stated |
| Cayenne Pepper (Capsicum annuum) | Plant | not stated |
| Grape seed extract | Plant | not stated |
| N-Acetyl Cysteine | Other substance | 200 mg |
| L-Histidine | Amino acid | 200 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Aller-Max
Entered into DSLD on 18 December 2021. Withdrawn from the US market on 9 May 2022 (according to the DSLD).- Same quantity, different name: Quercetin Dihydrate in this version; Quercetin on the displayed label (250 mg)
- Same quantity, different name: Stinging Nettle extract in this version; Stinging Nettle root extract on the displayed label (quantity not stated)
Official label: Aller-Max
Entered into DSLD on 28 May 2019. Withdrawn from the US market on 5 August 2021 (according to the DSLD).- Same quantity, different name: Stinging Nettle extract in this version; Stinging Nettle root extract on the displayed label (quantity not stated)
- Same quantity, different name: Olive leaf extract in this version; Zinc on the displayed label (10 mg)
- Different unit, without conversion : Vitamin A: 2,500 IU in this version; 750 mcg on the displayed label
Official label: Aller-Max
Entered into DSLD on 24 November 2015. Withdrawn from the US market on 27 November 2018 (according to the DSLD).- Active ingredient added : Stinging Nettle (100 mg)
- Active ingredient removed : Aller-Max Blend (225 mg)
- Active ingredient removed : Stinging Nettle root extract (quantity not stated)
- Same quantity, different name: Olive leaf extract in this version; Zinc on the displayed label (10 mg)
- Different unit, without conversion : Bromelain: 100 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Cayenne Pepper: 20 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Grape seed extract: 5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Vitamin A: 2,500 IU in this version; 750 mcg on the displayed label
Official label: Aller-Max
Entered into DSLD on 25 July 2014. Withdrawn from the US market on 28 August 2012 (according to the DSLD).- Active ingredient added : Cayenne (20 mg)
- Active ingredient added : Stinging Nettle (100 mg)
- Active ingredient removed : Aller-Max Blend (225 mg)
- Active ingredient removed : Calcium (50 mg)
- Active ingredient removed : Cayenne Pepper (quantity not stated)
- Active ingredient removed : Stinging Nettle root extract (quantity not stated)
- Same quantity, different name: Olive leaf extract in this version; Zinc on the displayed label (10 mg)
- Different unit, without conversion : Bromelain: 100 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Grape seed extract: 5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Vitamin A: 2,500 IU in this version; 750 mcg on the displayed label
Official label: Aller-Max
Entered into DSLD on 25 February 2013. Withdrawn from the US market on 8 October 2015 (according to the DSLD).- Active ingredient added : Cayenne (20 mg)
- Active ingredient added : Stinging Nettle (100 mg)
- Active ingredient removed : Aller-Max Blend (225 mg)
- Active ingredient removed : Calcium (50 mg)
- Active ingredient removed : Cayenne Pepper (quantity not stated)
- Active ingredient removed : Stinging Nettle root extract (quantity not stated)
- Same quantity, different name: Olive leaf extract in this version; Zinc on the displayed label (10 mg)
- Different unit, without conversion : Bromelain: 100 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Grape Seed Extract: 5 mg in this version; quantity not stated on the displayed label
- Different unit, without conversion : Vitamin A: 2,500 IU in this version; 750 mcg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Stinging Nettle root extract
Read the warning, when it applies and the studies cited
STINGING NETTLE JUICE
Route of administration: Oral
Cautions and warnings
Condition of application: All products except nutritive tonics.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.
Known adverse reactions
Condition of application: All products except those making only a diuretic claim*.
When using this product diuretic effect may occur.
*Note: This statement can be removed from the label if a diuretic claim is included.
Health Canada monograph dated 27 March 2026
STINGING NETTLE - URTICA DIOICA
Route of administration: Oral
Cautions and warnings
Condition of application: All products except nutritive tonics.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Tilgner S. Herbal Medicine from the Heart of the Earth. Creswell (OR): Wise Acre Press; 1999.
Known adverse reactions
All products except those making only a diuretic claim*
When using this product diuretic effect may occur.
*Note: This statement can be removed from the label if a diuretic claim is included.
- Cayenne Pepper
Read the warning, when it applies and the studies cited
CAYENNE - CAPSICUM ANNUUM Oral
Cautions and warnings
Condition of application: All products.
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).
Sources cited by Health Canada (2)
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Condition of application: Digestion; Peripheral circulation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical
Cautions and warnings
Condition of application: All products.
For external use only (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Known adverse reactions
Condition of application: All products.
Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).
Sources cited by Health Canada (5)
- APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
- Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
- McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
- Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Country Life
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.